AR014132A1 - Polipeptido que comprende un epitopo de un antigeno del t.cruzi, secuencia aislada de adn, vector de expresion recombinante, celula huesped, metodos parala deteccion de la infeccion por t. cruzi, kit de diagnostico, composicion farmaceutica, vacuna y polipeptido en combinacion - Google Patents

Polipeptido que comprende un epitopo de un antigeno del t.cruzi, secuencia aislada de adn, vector de expresion recombinante, celula huesped, metodos parala deteccion de la infeccion por t. cruzi, kit de diagnostico, composicion farmaceutica, vacuna y polipeptido en combinacion

Info

Publication number
AR014132A1
AR014132A1 ARP980106437A ARP980106437A AR014132A1 AR 014132 A1 AR014132 A1 AR 014132A1 AR P980106437 A ARP980106437 A AR P980106437A AR P980106437 A ARP980106437 A AR P980106437A AR 014132 A1 AR014132 A1 AR 014132A1
Authority
AR
Argentina
Prior art keywords
cruzi
composition
epitope
polypeptides
antigen
Prior art date
Application number
ARP980106437A
Other languages
English (en)
Spanish (es)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AR014132A1 publication Critical patent/AR014132A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ARP980106437A 1997-12-18 1998-12-17 Polipeptido que comprende un epitopo de un antigeno del t.cruzi, secuencia aislada de adn, vector de expresion recombinante, celula huesped, metodos parala deteccion de la infeccion por t. cruzi, kit de diagnostico, composicion farmaceutica, vacuna y polipeptido en combinacion AR014132A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/993,674 US6228372B1 (en) 1997-04-15 1997-12-18 Compounds and methods for the detection and prevention of T. cruzi infection

Publications (1)

Publication Number Publication Date
AR014132A1 true AR014132A1 (es) 2001-02-07

Family

ID=25539818

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980106437A AR014132A1 (es) 1997-12-18 1998-12-17 Polipeptido que comprende un epitopo de un antigeno del t.cruzi, secuencia aislada de adn, vector de expresion recombinante, celula huesped, metodos parala deteccion de la infeccion por t. cruzi, kit de diagnostico, composicion farmaceutica, vacuna y polipeptido en combinacion

Country Status (8)

Country Link
US (1) US6228372B1 (enExample)
EP (1) EP1038000A1 (enExample)
JP (1) JP2002508506A (enExample)
AR (1) AR014132A1 (enExample)
AU (1) AU1805799A (enExample)
BR (1) BR9813637A (enExample)
CO (1) CO4820439A1 (enExample)
WO (1) WO1999031246A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6419933B1 (en) * 1995-11-14 2002-07-16 Corixa Corporation Compounds and methods for the detection and prevention of T.cruzi infection
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US7695925B2 (en) * 2005-11-03 2010-04-13 Inbios International, Inc. Compositions and methods for the detection of Trypanosoma cruzi infection
US7749717B2 (en) * 2006-10-19 2010-07-06 Abbott Laboratories Methods for the detection and diagnosis of Trypanosoma cruzi infection
CA3023889A1 (en) * 2007-12-27 2009-07-09 Abbott Laboratories Anti-t. cruzi antibodies and methods of use
PT2291394T (pt) 2008-07-03 2017-06-05 Infectious Disease Res Inst Proteínas de fusão e seus usos no diagnóstico e tratamento de leishmaniose
WO2016071393A1 (en) * 2014-11-06 2016-05-12 Roche Diagnostics Gmbh Recombinant trypanosoma cruzi jl7 antigen variants and their use for detecting chagas disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
WO1990002564A1 (en) 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
BR9006039A (pt) 1990-11-28 1992-07-14 Fundacao Oswaldo Cruz Processo para preparacao de antigeno conjugado a atividade enzimatica,composicao a base de conjugado enzima-antigeno para utilizacao em diagnostico imunologico e kits de diagnostico imunologico da doenca de chagas a base da dita composicao,para aplicacao individual e/ou em inqueritos epidemiologicos
US5304371A (en) 1992-02-14 1994-04-19 Lasys Corporation Peptide for diagnosing and immunizing against T. cruzi infection
TW246717B (enExample) 1992-07-10 1995-05-01 Abbott Lab
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
US6228372B1 (en) 1997-04-15 2001-05-08 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection
US5916572A (en) 1995-11-14 1999-06-29 Corixa Corporation Compounds and methods for the detection and prevention of T. cruzi infection

Also Published As

Publication number Publication date
US6228372B1 (en) 2001-05-08
WO1999031246A1 (en) 1999-06-24
JP2002508506A (ja) 2002-03-19
EP1038000A1 (en) 2000-09-27
CO4820439A1 (es) 1999-07-28
BR9813637A (pt) 2001-12-04
AU1805799A (en) 1999-07-05

Similar Documents

Publication Publication Date Title
ES2734226T3 (es) Métodos, dispositivos, kits y composiciones para detectar gusanos látigo
JP6839485B2 (ja) ライム病抗体の検出のためのペプチドおよび方法
ES2743128T3 (es) Método y dispositivo para la detección combinada de infecciones víricas y bacterianas
ES2180754T3 (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
BRPI0411059B1 (pt) dispositivo de imunodiagnóstico para determinar a presença de um analito de interesse em uma amostra líquida, e, método de detecção de um anticorpo de interesse em uma amostra líquida
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
PT1190257E (pt) Deteccao precoce dos flavivirus, utilizando a glicoproteina ns1
US20180292401A1 (en) Immunoassay Utilizing Trapping Conjugate
DE60141844D1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
AR014132A1 (es) Polipeptido que comprende un epitopo de un antigeno del t.cruzi, secuencia aislada de adn, vector de expresion recombinante, celula huesped, metodos parala deteccion de la infeccion por t. cruzi, kit de diagnostico, composicion farmaceutica, vacuna y polipeptido en combinacion
Khalilpour et al. Lateral flow test using Echinococcus granulosus native antigen B and comparison of IgG and IgG4 dipsticks for detection of human cystic echinococcosis
Nagaoka et al. Antibodies against a short region of PfRipr inhibit Plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A
RU2000114841A (ru) Антитела против фосфорилированного vasp (стимулированного вазодилататором фосфопротеина), гибридомные клетки для их получения и их применение
SHAPIRO et al. Coated vesicles from the protozoan parasite Trypanosoma brucei: purification and characterization
AR023634A1 (es) Una composicion que comprende al menos 6 peptidos recombinantes y/o sinteticos, un metodo para detectar la presencia de un anticuerpo de t.cruzi, en una muestra biologica, y un estuche de diagnostico para su deteccion
BR0016458A (pt) Reagentes, métodos e kits para detectar proteìnas de bacillus thuringiensis
BRPI0406265A (pt) Método para análise eletroforética capilar, métodos para pesquisa e tipagem de proteìnas monoclonais, processo para preparação de anticorpos modificados, anticorpos modificados, kit para detecção e tipagem de proteìnas monoclonais e uso de anticorpos
Dmitriev et al. Western blot analysis of human and rat serotonin transporter in platelets and brain using site-specific antibodies: evidence that transporter undergoes endoproteolytic cleavage
WO2017201040A1 (en) Improved methods for monitoring immune status of a subject
Cima-Cabal et al. Protein expression analysis by western blot and protein–protein interactions
ES2372547T3 (es) Métodos para la detección y diagnosis de la infección por trypanosoma cruzi.
Lim et al. A direct sandwich ELISA to detect antibodies against the C-terminal region of merozoite surface protein 1 could be a useful diagnostic method to identify Plasmodium vivax exposed persons
Lin et al. Production of antibodies that recognize the heterogeneity of immunoreactive sites in human hemoglobin chemically modified by acetaldehyde
WO2007008092A3 (en) Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus

Legal Events

Date Code Title Description
FC Refusal